Karin Krause

Personalreferent bei DOTTIKON ES HOLDING AG

Vermögen: 560 257 $ am 30.04.2024

56 Jahre

9 Beziehungen

Process Industries

Non-Energy Minerals

Health Technology

Ursprung des Netzwerks ersten Grades von Karin Krause

Einheit	Art der Einheit	Industrie
Dottikon Exclusive Synthesis AG Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. 8	Subsidiary	Pharmaceuticals: Major	8
DOTTIKON ES HOLDING AG 7	Public Company	Chemicals: Specialty	7
Dottikon Es Management AG 6	Subsidiary		6

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Karin Krause

Unternehmen	Sektor	Verknüpfte Personen	Hauptposition
UBS	Investment Managers	Stephan Kirschbaum	Corporate Officer/Principal
Novartis Corp. Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.	Pharmaceuticals: Major	Thomas Früh	Corporate Officer/Principal
TRACON PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Alfred Scheidegger	Director/Board Member
BACHEM HOLDING AG	Pharmaceuticals: Major	Thomas Früh	Chief Executive Officer
Nextech Invest AG Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals.	Investment Managers	Alfred Scheidegger	Chief Executive Officer
University of California, Santa Barbara	College/University	Stephan Kirschbaum	Chief Tech/Sci/R&D Officer
University of Karlsruhe	College/University	Stephan Kirschbaum	Doctorate Degree
University of Basel	College/University	Alfred Scheidegger	Doctorate Degree
Swiss Federal Institute of Technology	College/University	Markus Blocher Thomas Früh Alfred Scheidegger Max Bachmann	Doctorate Degree Doctorate Degree Chief Administrative Officer Doctorate Degree
University of Bern	College/University	Emanuel Tschannen	Doctorate Degree
Evolma Holding AG		Markus Blocher Marlene Born	Chairman Director/Board Member
Systag System Technik AG Systag System Technik AG Medical SpecialtiesHealth Technology Systag System Technik AG specializes in laboratory automation. The private company is based in Ruschlikon, Switzerland. The Swiss company has been a leading partner for chemical and pharmaceutical production facilities worldwide since 1965. The CEO of the company is Marcel Haugg.	Medical Specialties	Markus Blocher Marlene Born	Chairman Director/Board Member
Kyoto University	College/University	Alfred Scheidegger	Graduate Degree
Swiss Chemical Society Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Swiss Chemical Society provides accounting services. The non-profit company is based in Bern, Switzerland.	Miscellaneous Commercial Services	Urs Brändli	Corporate Officer/Principal
Bachem Bioscience, Inc.		Thomas Früh	Chief Operating Officer
The Genetics Co., Inc. The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates.	Medical/Nursing Services	Alfred Scheidegger	Chairman
Bachem Americas, Inc. Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA.	Pharmaceuticals: Major	Thomas Früh	Chairman
Bachem AG Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland.	Pharmaceuticals: Major	Thomas Früh	Chief Operating Officer
Bachem Distribution Services Gmbh		Thomas Früh	Corporate Officer/Principal
Syngenta Crop Protection AG Syngenta Crop Protection AG Miscellaneous Commercial ServicesCommercial Services Syngenta Crop Protection AG engages in the research in as well as the development, production, and distribution of food, fiber, seeds, plants, as well as chemical and biological plant protection. The company was founded on December 3, 1996 and is headquartered in Basel, Switzerland.	Miscellaneous Commercial Services	Bernhard Urwyler	Corporate Officer/Principal
Migros Verteilzentrum Suhr AG		Marlene Born	Comptroller/Controller/Auditor
scienceindustries scienceindustries Miscellaneous Commercial ServicesCommercial Services scienceindustries operates as Swiss Business Association Chemistry Pharma Life Sciences. The firm represents the economic and political interests of its member companies. It also promotes the global competitiveness of its member companies by promoting an innovation-friendly environment and providing services for its members. The company was founded on December 23, 1944 and is headquartered in Zurich, Switzerland.	Miscellaneous Commercial Services	Thomas Früh	Corporate Officer/Principal
Nextech III GP AG		Alfred Scheidegger	Director/Board Member
Basel Chamber of Commerce Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business.	Miscellaneous Commercial Services	Thomas Früh	Director/Board Member
Bachem (U.K.) Ltd. Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow.	Pharmaceuticals: Major	Thomas Früh	Chairman
Cleave Therapeutics, Inc. Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA.	Biotechnology	Alfred Scheidegger	Director/Board Member
MFC Beteiligungs AG		Thomas Früh	Chairman
Evide AG Evide AG Food: Specialty/CandyConsumer Non-Durables Evide AG engages in trading of goods in the agricultural sector. It specializes in dried fruit products. The company was founded in 2008 and is headquartered in Huenenberg, Switzerland.	Food: Specialty/Candy	Markus Blocher	Chairman
Nextech Holding AG		Alfred Scheidegger	Chairman
Dottikon Es America, Inc.		Emanuel Tschannen Stephan Kirschbaum	Director/Board Member Chief Executive Officer
Mckinsey & Co., Inc. (Germany)		Stephan Kirschbaum	Corporate Officer/Principal
frugan Holding AG		Markus Blocher	Chairman
agrocult AG		Markus Blocher	Chairman
Cultivport AG		Markus Blocher	Chairman
Aerzte Treuhand G Deragisch		Marlene Born	Comptroller/Controller/Auditor
Swiss Scientific Computing Center Swiss Scientific Computing Center Miscellaneous Commercial ServicesCommercial Services The Swiss Scientific Computing Center develops and provides supercomputing capabilities to solve important problems in science and society. The private company is based in Manno, Switzerland.	Miscellaneous Commercial Services	Alfred Scheidegger	Chief Executive Officer
Nextech Venture Principals Ltd. Nextech Venture Principals Ltd. Financial ConglomeratesFinance Nextech Venture Principals Ltd. provides investment services. The private company is based in Jersey.	Financial Conglomerates	Alfred Scheidegger	Director/Board Member
Rising Tide Foundation	Investment Trusts/Mutual Funds	Alfred Scheidegger	Director/Board Member
Simplyscience Stiftung		Thomas Früh	Corporate Officer/Principal
Bachem Japan KK		Thomas Früh	Chairman
Simply Science Foundation		Thomas Früh	Chairman
8stogg AG		Alfred Scheidegger	Director/Board Member
Urwyler ChemPro GmbH		Bernhard Urwyler	Chief Executive Officer
Wemedoo AG		Alfred Scheidegger	Chairman